HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sofia R Gameiro Selected Research

Cetuximab (Erbitux)

11/2018Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sofia R Gameiro Research Topics

Disease

35Neoplasms (Cancer)
01/2022 - 09/2011
14Carcinoma (Carcinomatosis)
01/2022 - 09/2011
7Prostatic Neoplasms (Prostate Cancer)
11/2018 - 06/2010
6Breast Neoplasms (Breast Cancer)
01/2020 - 02/2016
3Neoplasm Metastasis (Metastasis)
01/2019 - 02/2012
2Inflammation (Inflammations)
01/2022 - 01/2020
2Necrosis
01/2021 - 01/2013
2Chordoma
11/2018 - 05/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2018 - 02/2012
1Sarcoma (Soft Tissue Sarcoma)
01/2022
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2018
1Triple Negative Breast Neoplasms
04/2016
1Hyperthermia
01/2013

Drug/Important Bio-Agent (IBA)

11VaccinesIBA
01/2022 - 06/2010
10AntigensIBA
01/2020 - 02/2012
7Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2014
6Immune Checkpoint InhibitorsIBA
01/2022 - 06/2013
6Histone Deacetylase InhibitorsIBA
01/2022 - 02/2016
6entinostat (MS 275)IBA
01/2022 - 02/2016
5Cancer VaccinesIBA
01/2022 - 06/2010
5Interleukin-12 (IL 12)IBA
01/2022 - 01/2019
5Interleukin-15 (Interleukin 15)IBA
01/2022 - 01/2019
5CytokinesIBA
01/2021 - 02/2012
4Granzymes (Granzyme)IBA
01/2020 - 02/2012
4Neoplasm Antigens (Tumor Antigens)IBA
01/2020 - 01/2013
4CalreticulinIBA
12/2016 - 01/2014
3LigandsIBA
01/2022 - 01/2018
3Immunoglobulin G (IgG)IBA
01/2020 - 01/2018
3Brachyury protein (Brachyury)IBA
01/2020 - 02/2016
3Monoclonal AntibodiesIBA
01/2019 - 01/2018
3Carcinoembryonic AntigenIBA
05/2016 - 02/2012
3AndrogensIBA
04/2016 - 10/2014
2Interferon-gamma (Interferon, gamma)IBA
01/2022 - 05/2014
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2021
2B7-H1 AntigenIBA
01/2022 - 01/2020
2ALT-803IBA
01/2020 - 01/2019
2Death Domain ReceptorsIBA
11/2018 - 01/2018
2avelumabIBA
11/2018 - 01/2018
2Histone Deacetylases (Histone Deacetylase)IBA
01/2018 - 02/2016
2VorinostatFDA Link
01/2018 - 02/2016
2Protons (Proton)IBA
12/2016 - 05/2016
2abirateroneIBA
04/2016 - 10/2014
2Androgen Receptors (Androgen Receptor)IBA
04/2016 - 10/2014
2enzalutamideIBA
04/2016 - 10/2014
2Adenosine Triphosphate (ATP)IBA
01/2014 - 08/2013
2HMGB1 Protein (HMG1)IBA
01/2014 - 08/2013
2PlatinumIBA
02/2012 - 09/2011
2Cisplatin (Platino)FDA LinkGeneric
02/2012 - 09/2011
2Vinorelbine (Navelbine)FDA LinkGeneric
02/2012 - 09/2011
1Programmed Cell Death 1 ReceptorIBA
01/2022
1Interleukin-12 Receptors (Interleukin 12 Receptor)IBA
01/2022
1CollagenIBA
01/2022
1ProteomeIBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2020
1Ado-Trastuzumab EmtansineIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1Peptides (Polypeptides)IBA
01/2019
1Blocking AntibodiesIBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1Cetuximab (Erbitux)FDA Link
11/2018
1olaparibIBA
11/2018
1adavosertibIBA
01/2018
1Phosphotransferases (Kinase)IBA
01/2018
1Complement System Proteins (Complement)IBA
01/2018
1RadiopharmaceuticalsIBA
12/2016
1Radium-223IBA
12/2016
1Mucin-1 (CA 15-3 Antigen)IBA
05/2016
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2016
1OsteoprotegerinIBA
04/2016
1Estrogen ReceptorsIBA
04/2016
1Histone Deacetylase 1IBA
02/2016
1Hormones (Hormone)IBA
10/2014
1Biological ProductsIBA
01/2014
1Docetaxel (Taxotere)FDA Link
08/2013
1Histocompatibility Antigens Class IIBA
01/2013
1ChemokinesIBA
02/2012
1PerforinIBA
02/2012
1yeast-CEA vaccineIBA
09/2011

Therapy/Procedure

16Immunotherapy
01/2020 - 02/2012
14Therapeutics
01/2022 - 06/2010
9Drug Therapy (Chemotherapy)
01/2020 - 06/2010
4Radiotherapy
01/2015 - 01/2014
3Castration
12/2016 - 06/2010
1Aftercare (After-Treatment)
08/2013
1Radiofrequency Ablation
01/2013
1Brachytherapy
02/2012